REVANCE THERAPEUTICS INC

CUSIP: 761330109 Class: Common Stock

Polar Capital Holdings Plc's Holding History (CIK: 0001837309)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 3,567,139 Value ($000) $9,168 Avg Close — Range —
Q1 2024
Shares 3,884,819 Value ($000) $19,113 Avg Close — Range —
Q4 2023
Shares 3,169,239 Value ($000) $27,858 Avg Close — Range —
Q3 2023
Shares 4,160,311 Value ($000) $47,719 Avg Close — Range —
Q2 2023
Shares 4,167,842 Value ($000) $105,488 Avg Close — Range —
Q1 2023
Shares 4,167,842 Value ($000) $134,246 Avg Close — Range —
Q4 2022
Shares 4,848,633 Value ($000) $89,506 Avg Close — Range —
Q3 2022
Shares 4,461,747 Value ($000) $120,467 Avg Close — Range —
Q2 2022
Shares 3,117,052 Value ($000) $43,078 Avg Close — Range —
Q1 2022
Shares 2,456,497 Value ($000) $47,902 Avg Close — Range —
Q4 2021
Shares 2,259,700 Value ($000) $36,878 Avg Close — Range —
Q3 2021
Shares 1,742,997 Value ($000) $48,560 Avg Close — Range —
Q2 2021
Shares 1,154,734 Value ($000) $34,226 Avg Close — Range —
Q1 2021
Shares 1,154,734 Value ($000) $32,275 Avg Close — Range —
Q4 2020
Shares 1,154,734 Value ($000) $32,725 Avg Close — Range —